In-unit particulate matter (PM2.5) in a public housing complex and the importance of tobacco and cannabis as indoor pollutants
Abstract
Fine particulate matter (PM 2.5 ) is a ubiquitous air pollutant with known socioeconomic disparities in exposure related to both ambient and indoor sources. Understanding how common indoor behaviors such as smoking, cooking, candle or incense burning, and air freshener use contribute to indoor PM 2.5 exposure in public housing can inform interventions to protect residents’ health. PM 2.5 data were collected via PurpleAir monitors for one week within 138 units of a public housing development in New England, United States and corrected via an additive relative humidity model. Study participants completed a pre-monitoring survey and a post-monitoring survey of in-unit PM 2.5 -related behaviors. Participants’ weekly average in-unit PM 2.5 levels were variable, ranging from 3.6 µg/m 3 to 142.0 µg/m 3 , with a mean of 19.7 µg/m 3 . Two-thirds (65.9%) of households’ average levels exceeded the EPA annual outdoor standard of 9 µg/m 3 , a heuristic reference given the lack of national indoor guidelines. A multivariable model predicting unit-level average PM 2.5 based on resident behaviors found significant associations between elevated PM 2.5 and past-week tobacco smoking (121% higher PM 2.5 ), weekly or more cannabis use (56% higher), and living in an apartment building rather than a townhome (26% higher). Cannabis use, which is studied here for the first time in an uncontrolled residential setting, may represent an underappreciated risk factor for exposure. Interventions directed…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.